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OPEN
ORIGINAL ARTICLE
The effects of maternal anxiety during pregnancy on IGF2/H19
methylation in cord blood
T Mansell1,2, B Novakovic1,2, B Meyer1,2, P Rzehak1,3, P Vuillermin1,2,4,5, A-L Ponsonby1,2, F Collier4,5, D Burgner1,2, R Saffery1,2,
J Ryan1,2,6,7 and BIS investigator team8
Compelling evidence suggests that maternal mental health in pregnancy can inﬂuence fetal development. The imprinted genes,
insulin-like growth factor 2 (IGF2) and H19, are involved in fetal growth and each is regulated by DNA methylation. This study aimed
to determine the association between maternal mental well-being during pregnancy and differentially methylated regions (DMRs)
of IGF2 (DMR0) and the IGF2/H19 imprinting control region (ICR) in newborn offspring. Maternal depression, anxiety and perceived
stress were assessed at 28 weeks of pregnancy in the Barwon Infant Study (n= 576). DNA methylation was measured in puriﬁed
cord blood mononuclear cells using the Sequenom MassArray Platform. Maternal anxiety was associated with a decrease in average
ICR methylation (Δ=− 2.23%; 95% CI =− 3.68 to − 0.77%), and across all six of the individual CpG units in anxious compared with
non-anxious groups. Birth weight and sex modiﬁed the association between prenatal anxiety and infant methylation. When
stratiﬁed into lower (⩽3530 g) and higher (43530 g) birth weight groups using the median birth weight, there was a stronger
association between anxiety and ICR methylation in the lower birth weight group (Δ=− 3.89%; 95% CI =− 6.06 to − 1.72%), with no
association in the higher birth weight group. When stratiﬁed by infant sex, there was a stronger association in female infants
(Δ=− 3.70%; 95% CI =− 5.90 to − 1.51%) and no association in males. All the linear regression models were adjusted for maternal
age, smoking and folate intake. These ﬁndings show that maternal anxiety in pregnancy is associated with decreased IGF2/H19 ICR
DNA methylation in progeny at birth, particularly in female, low birth weight neonates. ICR methylation may help link poor maternal
mental health and adverse birth outcomes, but further investigation is needed.
Translational Psychiatry (2016) 6, e765; doi:10.1038/tp.2016.32; published online 29 March 2016
INTRODUCTION
Maternal mental health during pregnancy has been linked with
poor fetal growth and lower birth weight,1–3 as well as adverse
health outcomes in childhood, including neurodevelopmental
delay,4,5 attention problems and depressive symptoms.6–8 An
adverse in utero environment is speculated to lead to ‘pro-
grammed’ changes in the fetus during development,9 and
epigenetic processes including DNA methylation are thought to
have an important role.9,10 Indeed, increasing evidence has shown
that maternal mental well-being during pregnancy, inﬂuenced by
factors such as stress, anxiety and depression, can inﬂuence DNA
methylation levels of the glucocorticoid receptor gene in the
neonate.11 Several recent studies also provide preliminary
evidence that maternal mental health during pregnancy can
result in differential methylation levels in imprinted genes in the
offspring.12–14 Infants born to women with severe depression
during pregnancy (n= 32) had higher cord blood methylation of
the MEG3 imprinted gene than infants born to 271 non-depressed
women.12 Similarly, cord blood methylation of another imprinted
gene, MEST, was positively correlated with maternal perceived
stress during pregnancy in a recent study of 79 mother–infant
pairs.14
Imprinted genes are involved in a number of pathways crucial
for fetal growth,15 and alleles for imprinted genes are expressed
according to parental origin. DNA methylation levels differ
between parental alleles at imprinted genes in association with
differential gene expression.16 Of particular interest are the
reciprocally imprinted IGF2/H19 genes. IGF2 encodes insulin-like
growth factor 2 (IGF2), the major growth hormone during fetal
life,17 expressed speciﬁcally from the paternal allele, whereas the
downstream H19 gene is speciﬁcally expressed from the maternal
allele.18 The imprinting pattern is regulated by methylation at the
imprinted control region (ICR) and is associated with several
differentially methylated regions (DMRs) in the IGF2 and H19 gene
promoters.19 Of note, methylation of IGF2 DMR0 and DMR2 has
been linked with infant birth weight.20 Offspring IGF2 and H19
methylation has been shown to be inﬂuenced by in utero
exposures. For example, lower IGF2 DMR0 methylation has been
reported in the whole blood of adults born to mothers who
experienced famine during the Dutch Hunger Winter,21 whereas
elevated DMR0 methylation22 and lower H19 promotor DMR23 has
been found in infants exposed to folic acid supplementation
during pregnancy. Higher H19 promoter DMR methylation has
been found in association with macronutrient intake in a study
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that combined measurements from buccal, cord blood, umbilical
vein endothelium and placenta and granulocytes cells.23 Maternal
smoking during pregnancy has also been shown to inﬂuence
newborn IGF2 DMR0 and H19 promotor DMR methylation.13,24
Two recent studies have found evidence of associations
between maternal mental health and methylation of H19 and
IGF2. Chen et al.25 reported increased methylation of the ICR
located upstream of H19 in cord blood and placenta tissue of
infants born to mothers with high self-reported stress and anxiety,
whereas Vangeel et al.26 found decreased methylation of IGF2
DMR0 in association with maternal anxiety. These ﬁndings based
on relatively small sample sizes (no100) have not yet been
replicated. The associations between maternal mental well-being
and IGF2/H19 methylation may differ across ethnic groups,13 and
could vary depending on the infant’s gender and birth weight.12,14
Given the multitude of factors known to inﬂuence DNA
methylation both temporally and spatially, ascertaining the effects
of any exposure in utero on infant outcome are best addressed
using large, well-characterized population-based birth cohort
studies with robust measurements of exposure and biospecimens
collected at birth.
In the current study, we assessed whether maternal mental
health during pregnancy (depression, anxiety and perceived
stress) was associated with cord blood methylation, focusing on
the IGF2/H19 ICR, one of the key imprinted loci, and IGF2 DMR0.
These two regions are of particular interest given that they have
been the most widely studied in previous studies and have been
shown to be differentially methylated in response to other in utero
exposures.21,23,25,27–30 Second, we aimed to determine whether
other key factors such as maternal smoking during pregnancy,
infant gender and birth weight, inﬂuenced this association.
MATERIALS AND METHODS
Study population
The prospective Barwon Infant Study31 is a population-derived birth cohort
of mother–infant dyads (n=1074). The study was established in 2010 to
investigate the developmental and early-life origins of non-communicable
disease.32 The study protocol was approved by the Barwon Health Human
Research Ethics Committee, and the participants provided written
informed consent.
Women were recruited from two hospitals in the Geelong region of
Victoria between 15 and 28 weeks of pregnancy; Geelong Hospital (public)
and St John of God Hospital (private). Those invited to participate needed
to be living in the Barwon region, an Australian citizen or permanent
resident, aged at least 18 years at 28 weeks of pregnancy and able to
complete questionnaires and provide informed consent. Women were
excluded from participating if they already had another child in the study
(with the exception of twins), or had planned to privately store their cord
blood. Following birth, neonates were excluded if they were born before
32 weeks gestation, diagnosed with a serious illness at birth or had a
genetically determined disease or major congenital malformation. Twins
were also excluded from the current analysis.
At 28 weeks gestation, mothers were administered comprehensive
questionnaires to gather sociodemographic, clinical and health-related
information. This included parental age, education levels and ancestry.
Maternal alcohol consumption and tobacco smoking across pregnancy
were also recorded, as were pregnancy-related health conditions, such as
preeclampsia, hypertension and gestational diabetes (based on standard
criteria). At birth, information was gathered from medical records,
including the neonate’s gender, gestational age and birth weight.
Maternal mental well-being during pregnancy
Speciﬁc aspects of maternal mental well-being during the twenty-eighth
week of pregnancy were assessed using two validated and widely used
self-report questionnaires. The 10-item Edinburgh Depression Scale
(EDS) 33 is a questionnaire focused on mood and feelings over the past
week.34 It provides an assessment of depression and anxiety symptoms,
which can be distinguished from one another reliably (reviewed by Matthey
et al.,35 where Cohen’s d ranged from 0.61 to 1.41 across ﬁve different
studies). We classiﬁed women as having clinically signiﬁcant levels of
depression if they scored 10 or more on the EDS, based on previous reports
that this provided optimal sensitivity and speciﬁcity.36 This cut-off is also
the most widely used in the literature. Anxiety symptoms were deﬁned as a
score of 5 or more on the EDS anxiety subscale, as previously described.37,38
Maternal psychological stress during pregnancy was assessed with the
validated Perceived Stress Scale.39 This 14-item questionnaire focuses on
perceived stress experienced in the last month, and has been shown to
provide a more accurate reﬂection of the biological impact of psycholo-
gical stress compared with measuring stressful life events.40 The Perceived
Stress Scale scores ranged from 0 to 50, with higher scores indicating
greater distress.
Cord blood processing
The umbilical cord blood was collected at delivery and processed within
18 h. Density gradient centrifugation (Lymphoprep, AxisShield, Dundee,
UK) was used to isolate mononuclear cells from the whole-blood sample,
and cell number and viability assessed by Trypan Blue staining. The cell
composition of each cord blood mononuclear cells sample (lymphocyte,
monocyte and/or contaminating erythrocytes) was determined by ﬂow
cytometry. The cells were stained with antibodies to CD3-FITC, CD4-PE and
CD45-PerCP (BD Biosciences, San Jose, CA, USA). To evaluate the relative
frequency of lymphocyte, monocyte and any contaminating nucleated
erythrocytes, the cell populations were gated on the basis of CD45
positivity and granularity (high side scatter, SSC).
DNA methylation
The assays were designed using the EpiDesigner software (www.
epidesigner.com) to cover the key regions of IGF2 and H19 identiﬁed in
previous studies.41 The cleavage patterns were determined using the
Bioconductor MassArray package in R (www.bioconductor.org). For IGF2
DMR0, the primers (forward 5′-TGGATAGGAGATTGAGGAGAAA-3′; reverse
5′-AAACCCCAACAAAAACCACT-3′) ampliﬁed a 338 bp DMR of the promo-
ter (hg_18:chr11:2126035–2126372). For the IGF2/H19 ICR, the primers
(forward 5′-TATGGGTATTTTTGGAGGTTTTTTT-3′; reverse 5′-
AACTTAAATCCCAAACCATAACACT-3′) ampliﬁed a 316 bp DMR of the ICR
(hg_18:chr11:1977554–1977869). For both the assays, the forward primer
contained a balance tag (AGGAAGAGAG) and the reverse primer a T7 tag
(5′- CAGTAATACGACTCACTATAGGGAGAAGGCT-3′).
The QIAamp DNA Mini Kit (QIAGEN, Chadstone, Australia) was used to
extract DNA. The EZ-96 DNA Methylation-Gold kit (Zymo Research, Irvine,
CA, USA) was used for bisulphite conversion of 500 ng of genomic DNA.
SEQUENOM MassARRAY (San Diego, CA, USA) and the EpiTyper software
(v.1.2; SEQUENOM) were used for the quantiﬁcation of DNA methylation.42
All the samples were ampliﬁed and assayed in triplicate. Technical
replicates which deviated from the mean by 10% or more were excluded,
and the mean of the duplicates was used for subsequent analysis. If two or
more of the triplicates deviated from one another, the sample was
considered as missing and not used for the subsequent analysis given that
it was unreliable. If o70% of the mean values were successfully measured
for a given CpG site, or if o70% of CpG sites were successfully measured
for a given sample, this was excluded.
Statistical analysis
The study sample was 576 mother–infant dyads with complete information
on the maternal mental well-being during pregnancy and DMR0 and/or
ICR methylation data. Compared with the complete BIS population, the
participants included in this study did not differ in sociodemographic or
health status (data not shown).
Pair-wise correlations, t-tests, analysis of variance and chi-squared tests
(as appropriate) were used to determine the association between speciﬁc
maternal mental health measures during pregnancy and characteristics of
the mother–infant dyads, as well as the association between these
characteristics and DNA methylation. Multiple linear regression models
were constructed to examine the association between the maternal mental
health and CpG methylation while adjusting for potential confounding
factors. Although none of the maternal or infant characteristics (listed in
Table 1) were associated with both the exposure and outcome at Po0.1,
we ensured that their inclusion in the model did not inﬂuence the
associations found. The cell composition as well as possible batch effects
from individual SEQUENOM were also considered as potential confounding
factors in the analysis. We also investigated the possibility that the
association between maternal mental health and DNA methylation
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differed across strata of participants. First-order interaction terms were
investigated with maternal smoking, infant gender and birth weight (both
raw and adjusted birth weight, taking into account gestational age and
infant sex43) by including a product term in the regression models. If an
interaction was found, stratum-speciﬁc results are reported. All the
statistical analysis was undertaken using Stata 14 IC version (StataCorp,
College Station, TX, USA).
RESULTS
Mothers in the study had a mean age at delivery of 32.1 years (s.
d. = 4.5) and 46.0% (265/576) were educated to at least a
university graduate level. The prevalence of maternal smoking
and drinking was 9.2% (53/576) and 11.6% (63/576), respectively.
One-hundred and six women reported depressive symptoms
during pregnancy (18.4% of 576), and 19.3% (111/576) of women
had anxiety symptoms (of which 76 had both anxiety and
depressive symptoms). The mean perceived stress scores were
18.9 (s.d. = 7.1), and ranged from 2 to 44. The three mental health
measures were highly correlated with one another (Po0.0001). In
terms of the association between maternal mental health and
maternal health during pregnancy, anxiety during pregnancy was
associated with increased incidence of hypertension (P= 0.023)
and perceived distress was associated with gestational diabetes
(P= 0.010). All mental health measures were associated with a
small decrease in gestational age (Po0.02 for each) but there was
no association between maternal mental health and birth weight
(anxious, P= 0.28; depressed, P= 0.74; perceived distress, P= 0.89)
or birth weight adjusted for gestational age (anxious, P= 0.70;
depressed, P= 0.21; perceived stress, P= 0.36).
The mean and standard deviation of IGF2 DMR0 and IGF2/H19
ICR DNA methylation levels in the sample as well as the mass
spectrometry success rate at individual CpG units and the average
level across the regions are shown in Supplementary Table 1. The
methylation levels at all the included CpG units were normally
distributed. Within the DMR0 and ICR regions, methylation levels
at the individual CpG units were correlated with one another
(Po0.01, data not shown). The characteristics of the participants
and average DMR0 and ICR methylation are shown in Table 1.
None of the characteristics were signiﬁcantly associated with
average DNA methylation of either region; however, increased
DMR0 methylation was observed in infants born to mothers with
gestational diabetes (P= 0.06), compared with those without.
We ﬁrst investigated whether DMR0 and ICR mean methylation
levels differed according to maternal mental health status during
pregnancy. In unadjusted analysis, maternal anxiety symptoms
were found to be associated with a 2.23% decrease in average ICR
methylation across the region (95% CI = 0.77 to 3.68%; P= 0.003).
At individual CpG units, a number of group differences were also
observed, in each case with decreased methylation levels in the
anxious group: 2.48% difference at CpG 1 (95% CI = 0.84 to 4.12%;
P= 0.003); 1.94% at CpG 5.6.7.8 (95% CI = 0.36 to 3.52%; P= 0.02);
2.13% at CpG 11.12 (95% CI = 0.60 to 3.66%; P= 0.01); and 2.38% at
CpG 13.14 (95% CI = 0.80 to 3.96%; P= 0.003; Figure 1). At the
other CpG units, 21.22 and 23, there was a trend of decreased
Table 1. Average methylation of IGF2 DMR0 and IGF2/H19 ICR DMR
according to participant characteristics
Characteristics Average IGF2 DMR0
methylation
Average IGF2/H19
ICR methylation
r P r P
Maternal age (years) 0.021 0.64 0.025 0.60
Mean % (55) P Mean (55) P
Maternal education 0.26 0.17
⩽Year 10 52.55 (5.12) 44.20 (5.50)
Year 11 or 12 51.67 (6.43) 41.25 (6.44)
University graduate or
above
52.86 (6.13) 41.92 (6.71)
Other 52.68 (5.74) 41.58 (5.04)
Paternal education 0.96 0.59
⩽Year 10 52.22 (6.21) 42.55 (5.98)
Year 11 or 12 52.63 (6.00) 42.07 (6.18)
University graduate or
above
52.36 (6.50) 41.36 (6.45)
Other 52.34 (5.54) 41.33 (7.23)
Infant ancestry 0.15 0.21
British 52.04 (6.20) 42.18 (5.58)
Mixed 52.66 (6.18) 41.28 (6.76)
Non-British 53.59 (5.32) 42.60 (7.65)
Smoking during pregnancy
No 52.49 (6.12) 0.69 41.91 (6.55) 0.39
Yes 52.84 (5.52) 41.05 (4.54)
Alcohol during pregnancy
No 52.51 (6.15) 0.80 41.75 (6.38) 0.63
Yes 52.29 (5.86) 42.16 (6.07)
Gestational diabetes
No 52.41 (6.10) 0.06 41.85 (6.30) 0.28
Yes 54.74 (5.90) 40.29 (7.92)
Hypertension
No 52.64 (5.88) 0.13 41.81 (6.31) 0.74
Yes 51.22 (8.06) 41.48 (7.16)
Preeclampsia
No 52.55 (6.00) 0.48 41.83 (6.24) 0.25
Yes 51.34 (9.39) 39.58 (11.04)
Child sex
Male 52.20 (5.85) 0.20 41.74 (6.26) 0.68
Female 52.87 (6.38) 41.98 (6.60)
r P r P
Child gestational age
(days)
− 0.020 0.67 0.060 0.24
Child birth weight (g) − 0.011 0.80 − 0.032 0.49
Antenatal folate
(nmol l− 1)
0.019 0.67 0.031 0.51
Abbreviations: DMR, differentially methylated region; ICR, imprinting
control region.
*
* * *
*
Figure 1. Population distribution of IGF2/H19 ICR DMR methylation
levels in infants born to anxious and non-anxious mothers.
*P⩽ 0.016. Error bars are standard deviation. DMR, differentially
methylated region; ICR, imprinting control region.
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methylation in the anxiety group (CpG 21.22: Δ=− 1.70%, 95%
CI =− 3.59 to 0.19%, P= 0.078; CpG 23: Δ=− 1.79%, 95% CI =
− 3.90 to 0.32%, P= 0.096). Maternal anxiety was also associated
with a 1.83% decrease at DMR0 CpG 3 speciﬁcally, (95% CI = 0.28
to 3.38%, P= 0.02), but no association was observed between
anxiety and average DMR0 methylation. There were similar
associations with ICR methylation found for maternal depression
and perceived stress (particularly at CpG 1, CpG 11.12 and CpG
13.14), but these were weaker and less consistent than with
anxiety (Supplementary Table 2). In linear regression models
adjusted for key covariates previously reported to inﬂuence DNA
methylation levels and possibly associated with maternal mental
health, for example, maternal age, smoking and folate, infant
gender and birth weight (raw and adjusted z-scores), these
associations persisted (Supplementary Table 3).
There was also some evidence of effect modiﬁcation in the
association between anxiety and ICR methylation according to
birth weight (P for interaction 0.03 for average methylation, 0.10
for CpG 1, 0.05 for CpG 5.6.7.8, 0.08 for CpG 13.14, 0.02 for CpG
21.22) and infant sex (average methylation, P for interaction 0.07).
To investigate how the association between maternal anxiety
during pregnancy and ICR methylation varied according to birth
weight, we repeated the analysis in groups stratiﬁed by birth
weight. There were too few infants in the clinically deﬁned low
(o2500 g) or high birth weight (44500 g) groups, so we created
a binary group using the median (3530 g) birth weight. The results,
as shown in Table 2, indicate that maternal anxiety during
pregnancy was strongly associated with lower ICR methylation in
the lower birth weight group (⩽3530 g) only. The maternal anxiety
was associated with a 3.89% decrease in average ICR methylation
(95% CI = 1.72 to 6.06%, Po0.001), however, no such association
was observed in the higher birth weight group (Δ=− 0.59%, 95%
CI =− 2.54 to 1.37%, P= 0.55; Supplementary Figure 1). When the
analysis was repeated with birth weight adjusted for gestational
age and infant sex, ﬁndings were consistent with those using raw
birth weight.
Given our previous observation that infant sex also modiﬁed the
association between anxiety and DNA methylation, sex-stratiﬁed
analysis was undertaken. The results showed a female-speciﬁc
association between anxiety and decreased ICR methylation
(Supplementary Table 4), which corresponded to a mean 3.70%
decrease in average ICR methylation (95% CI = 1.51 to 5.90%,
P= 0.001), and varied from 2.71% to 3.36% at the individual CpG
units. No associations were found in males.
As female infants were more likely to be in the lower birth
weight group than males (57 versus 44%), we further investigated
how the association between anxiety and DNA methylation
differed across groups deﬁned by both gender and birth weight
(Figure 2). The strongest association between maternal anxiety
during pregnancy and infant ICR methylation was observed for
female infants in the lower birth weight group, with a 3.86%
decrease in methylation levels. For all the results, sensitivity
analysis conﬁrmed that the removal of outliers (represented by
individual points in Figure 2 and Supplementary Figure 1) did not
alter the ﬁndings.
DISCUSSION
This study utilized data gathered from a large longitudinal birth
cohort to investigate the association between speciﬁc maternal
mental health measures and infant methylation of the IGF2/H19
ICR and IGF2 DMR0. We report strong and consistent evidence of
an association between maternal anxiety and decreased IGF2/H19
ICR methylation at the major CpG sites across the region
investigated and these associations persisted when accounting
for a range of covariates. Similar, but weaker, associations were
also observed with maternal depression and perceived stress
during pregnancy. The maternal mental well-being is one of a
number of environmental factors which have now been shown to
Table 2. Difference in DNA methylation levels between neonates born to anxious versus non-anxious mothers, stratiﬁed by birth weight
CpG unit Lower birth weight (⩽ 3530 g) Higher birth weight (43530 g)
Δ 95% CI P Δ 95% CI P
IGF2 DMR0
3 − 1.66% − 3.91 to 0.59% 0.15 − 1.96% − 4.10 to 0.18% 0.072
4 0.30% − 2.23 to 2.84% 0.81 0.40% − 2.89 to 3.70% 0.81
6.7 − 0.88% − 2.78 to 1.01% 0.36 0.79% − 0.86 to 2.14% 0.34
Average − 1.00% − 2.71 to 0.70% 0.25 − 0.09% − 2.04 to 1.85% 0.92
IGF2/H19 ICR
1 − 4.33% − 6.83 to − 1.84% 0.0007 − 0.70% − 2.83 to 1.44% 0.52
5.6.7.8 − 3.40% − 5.71 to − 1.10% 0.0040 − 0.45% − 2.63 to 1.73% 0.68
11.12 − 3.82% − 6.10 to − 1.55% 0.0011 − 0.47% − 2.53 to 1.63% 0.66
13.14 − 4.57% − 6.99 to − 2.14% 0.0003 − 0.25% − 2.31 to 1.80% 0.81
21.22 − 3.76% − 6.49 to − 1.04% 0.0071 0.27% − 2.35 to 2.88% 0.84
23 − 2.21% − 5.19 to 0.78% 0.15 − 1.49% − 4.47 to 1.49% 0.33
Average − 3.89% − 6.06 to − 1.72% 0.0005 − 0.59% −2.54 to 1.37% 0.55
Abbreviations: DMR, differentially methylated region; ICR, imprinting control region.
*
Figure 2. Population distribution of IGF2/H19 ICR DMR methylation
levels in non-anxious and anxious groups, stratiﬁed by both infant
sex and birth weight. *P= 0.0001. BW, birth weight; DMR,
differentially methylated region; ICR, imprinting control region.
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inﬂuence IGF2 and H19 methylation, along with smoking,24
antidepressant use13 and famine.21 Only two smaller studies
(no100) have previously considered the association between
maternal anxiety and IGF2/H19 methylation, and their ﬁndings
have not yet been replicated.25,26
Some recent studies have investigated possible associations
between maternal mental health and infant IGF2 and H19
methylation in cord blood. Of these, one study has examined
the relationship between anxiety and methylation of ICR CpGs 11
to 17, as measured here. This small study25 contrasted with our
own ﬁndings and reported increased methylation in association
with maternal anxiety (measured by the State-Trait Anxiety
Inventory) and perceived stress (Perceived Stress Scale) in cord
blood but no association was found in matched placental tissue.
However, this study considered only 49 mother–infant dyads and
the association between anxiety and methylation did not persist
when considering anxiety disorders diagnosed through clinical
interviews. Two other studies using cord blood have investigated
the association between anxiety, IGF2 and ICR methylation, but
they assayed slightly different gene regions compared with our
own study. One small study (n= 80), focussing on maternal anxiety
measured using the Pregnancy-Related Anxiety Questionnaire,
found a decrease in DMR0 methylation at a CpG site outside our
assay.26 The other larger study (n= 508) considered self-reported
anxiety, but reported no association at either a region upstream of
IGF2 exon 3 or the ICR.12 These two studies also investigated
depression, one ﬁnding decreased methylation at a CpG site
outside our assayed region26 and the other ﬁnding no association
with methylation of either region, though an association was
reported at another imprinted gene, MEG3.12 Two further studies
using cord blood samples have investigated IGF2 and H19, albeit
at different regions to our study, and have not considered anxiety.
A pregnancy cohort partially enriched for smokers (n= 436) found
no association between self-reported depression and DNA
methylation levels.13 Birth weight, but not infant sex was
considered as a covariate in their analysis. The other small study
(n= 79) investigated potential associations between perceived
stress (Perceived Stress Scale) and methylation of nine imprinted
gene DMRs, including IGF2 and H19.14 The only association
observed was increased methylation at the MEST imprinted gene.
We found that the association between maternal anxiety and
decreased ICR methylation differed according to birth weight and
infant sex, being strongest in low birth weight infants and girls.
This is notable as maternal anxiety and decreased infant IGF2/H19
ICR methylation have both previously been linked with lower birth
weight,20,44 though we did not observe such an association in this
study. Gender-speciﬁc associations have also been reported
previously, with stronger effects of adverse maternal mental
health reported in females for methylation of IGF2, MEG3 (ref. 12)
and MEST.14
Our ﬁnding of decreased ICR methylation in neonates born to
mothers with anxiety could help to explain the previously
reported link between poor maternal mental health and adverse
birth outcomes, including low birth weight and neural tube
defects.1,45,46 The methylation of the IGF2/H19 ICR on the maternal
allele prevents the binding of transcriptional repressor CTCF,
which allows access to the downstream enhancer region of IGF2.
This promotes IGF2 expression to produce insulin-like growth
factor 2.47 The IGF2 protein binds to insulin-like growth factor 1
receptor (encoded by IGF1R), a kinase activator that promotes cell
survival and proliferation signals48 and consequently promotes
fetal growth. In contrast, when CTCF is bound, this allows H19 to
be expressed to produce miR-675, which has been shown to
supress growth during gestation and is linked to downregulation
of IGF1R.49 Increased IGF2 DRM0 methylation has also been linked
to decreased IGF2 mRNA expression levels.50 In turn, this has been
associated with lower birth weight20 and other health problems
such as neural tube defects.50
A strength of our study is the large well-characterized cohort,
which has allowed us to consider a range of covariates in the
analysis, including several that have previously been associated
with ICR methylation. However, we found no independent
association between any covariates and DNA methylation levels
of DMR0 and ICR. IGF2 and H19 are known to have a role in
regulating fetal growth through insulin-like growth factor 2 (refs
48,49) and an earlier study has reported a weak positive
correlation between birth weight and IGF2/H19 ICR methylation in
twins.41 Decreased IGF2 methylation has also been found in
clinically low birth weight infants compared with those of normal
birth weight.12 As only six infants in our study could be considered
clinically low birth weight infants (o2500 g), this may help
explain the lack of independent association between birth weight
and IGF2 methylation demonstrated here. Another limitation of
our study is the single measurement of maternal mental health
made at 28 weeks gestation, which means we cannot generalize
these ﬁndings to mental health status at the other stages of
pregnancy. However, a prior study that collected multiple
measurements throughout pregnancy reported that second
trimester scores for depression, anxiety and perceived stress were
highly correlated with scores at other time points.51 In addition, a
study investigating the association between maternal mental
health during pregnancy and neonate methylation of another
gene involved in stress signalling found that the second trimester
mental health scores were more strongly associated with neonate
methylation than the ﬁrst or third trimester scores.52 We
considered three distinct mental health exposures, and found
similar, though weaker, associations with perceived stress as
reported for anxiety. Increased perceived stress was also
associated with decreased neonate ICR methylation, particularly
at CpGs 1, 11.12 and 13.14. Finally, the difference in ICR
methylation between anxious and non-anxious groups found in
this study is relatively small. It is possible that the accumulation of
small differences in methylation like this across multiple genes
within the same biological pathway or in the broader epigenome
might be what leads to signiﬁcant increases of risk of disease in
later life, and other studies investigating the effects of maternal
mental well-being on neonate methylation have reported similarly
small effect sizes,12,14,52–55 supporting our own ﬁndings. On the
basis of previous studies,47,56 decreased ICR methylation would be
predicted to lead to reduced CTCF binding and consequently
reduced IGF2 expression, but the potential long-term impact on
the neonate’s health and development has yet to be established.
Although IGF2/H19 ICR methylation is associated with fetal
growth,57 it is unknown how persistent these changes are into
later life and whether they are transient during development or
are established as disrupted methylation patterns that remain
over time.
CONCLUSION
This study provides consistent evidence in a large, well-
characterized population-based birth cohort of a prospective
association between maternal anxiety during pregnancy and
reduced infant IGF2/H19 ICR cord blood methylation. This
association persisted when accounting for a range of lifestyle
and birth-related covariates, but appeared to be gender-speciﬁc
and stronger for lower birth weight infants. Though we provide
evidence for a potential link between measures of maternal well-
being during pregnancy and adverse birth outcomes, possibly
through differential IGF2/H19 ICR methylation observed at birth,
this has yet to be replicated. Further work is required to
characterize the relationships between maternal anxiety, IGF2/
H19 ICR methylation, birth outcomes and subsequent long-term
offspring health.
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